- Home
- APLT vs CLB Comparison
APLT vs CLB Comparison
Compare APLT & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- CLB
- Stock Information
- Founded
- APLT 2016
- CLB 1936
- Country
- APLT United States
- CLB United States
- Employees
- APLT N/A
- CLB N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- CLB
- Sector
- APLT Health Care
- CLB
- Exchange
- APLT Nasdaq
- CLB Nasdaq
- Market Cap
- APLT 63.6M
- CLB 482.5M
- IPO Year
- APLT 2019
- CLB 1995
- Fundamental
- Price
- APLT $0.42
- CLB $12.44
- Analyst Decision
- APLT Buy
- CLB Hold
- Analyst Count
- APLT 6
- CLB 2
- Target Price
- APLT $6.10
- CLB $12.50
- AVG Volume (30 Days)
- APLT 876.2K
- CLB 505.4K
- Earning Date
- APLT 11-06-2025
- CLB 10-22-2025
- Dividend Yield
- APLT N/A
- CLB 0.32%
- EPS Growth
- APLT N/A
- CLB 23.99
- EPS
- APLT N/A
- CLB 0.62
- Revenue
- APLT $121,000.00
- CLB $517,378,000.00
- Revenue This Year
- APLT N/A
- CLB N/A
- Revenue Next Year
- APLT $5,931.24
- CLB $2.23
- P/E Ratio
- APLT N/A
- CLB $20.18
- Revenue Growth
- APLT N/A
- CLB 0.70
- 52 Week Low
- APLT $0.30
- CLB $9.72
- 52 Week High
- APLT $10.62
- CLB $21.83
- Technical
- Relative Strength Index (RSI)
- APLT 38.07
- CLB 59.90
- Support Level
- APLT $0.43
- CLB $12.07
- Resistance Level
- APLT $0.46
- CLB $12.82
- Average True Range (ATR)
- APLT 0.03
- CLB 0.49
- MACD
- APLT -0.01
- CLB 0.11
- Stochastic Oscillator
- APLT 11.08
- CLB 67.65
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.